Mental health services utilization and expenditures associated with cancer survivorship in the United States

Journal of Cancer Survivorship

Volumn 9, Issue 1, 2015, Pages 50-58

  Li, Chunyu ^a   Li, Chenghui ^b   Forsythe, Laura ^c   Lerro, Catherine ^d   Soni, Anita ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Patient Centered Outcomes Research Institute (PCORI)   (United States)

^d AMERICAN CANCER SOCIETY   (United States)

^e AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Cancer; Expenditures; Mental health; Prescription drug; Utilization

Indexed keywords

ADOLESCENT; ADULT; ECONOMICS; FEMALE; HUMAN; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; MORTALITY; NEOPLASM; PSYCHOLOGY; SURVIVOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; NEOPLASMS; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84905326819     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-014-0392-0     Document Type: Article

References (38)

1. Adler N, Page A, eds. Cancer Care for the Whole Patient: meeting Psychosocial Healthcare Needs. Washington DC: Institute of Medicine (IOM). 2008.
2. Hewitt M, Greenfield S, Stovell E, editors. From cancer patient to cancer survivor: lost in transition. Washington DC: National Academies Press; 2006.
3. Holland J, Weiss T. The new standard of quality cancer care: integrating the psychosocial aspects in routine cancer from diagnosis through survivorship. Cancer J. 2008;14:425–8.
4. Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv. 2009;3:43–58.
5. Butler L, Downe-Wamboldt B, Melanson P, et al. Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nurs. 2006;29:9–16.
6. Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol. 2010. doi:10.1200/JCO.2009.26.9357.
7. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115:5349–61.
8. Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for all-cause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv. 2013;7(3):484–92.
9. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.
10. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:160–74.
11. Earle CC, Neville BA, Fletcher R. Mental health service utilization among long-term cancer survivors. J Cancer Surviv. 2007;1:156–60.
12. Kaiser NC, Hartoonian N, Owen JE. Toward a cancer-specific model of psychological distress: population data from the 2003–2005 National Health Interview Surveys. J Cancer Surviv-Res Pract. 2010;4:291–302.
13. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.
14. Parry C, Kent EE, Mariotto AB, et al. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.
15. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526–31.
16. Zuvekas SH. Trends in mental health services use and spending, 1987–1996. Health Aff (Millwood). 2001;20:214–24.
17. Carlson LE, Bultz BD. Benefits of psychosocial oncology care: improved quality of life and medical cost offset. Health Qual Life Outcomes. 2003;1:8.
18. Carlson LE, Bultz BD. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology. 2004;13:837–49. discussion 850–836.
19. Gordon LG, Beesley VL, Scuffham PA. Evidence on the economic value of psychosocial interventions to alleviate anxiety and depression among cancer survivors: a systematic review. Asia Pac J Clin Oncol. 2011;7:96–105.
20. Hewitt M, Rowland JH. Mental health service use among adult cancer survivors: analyses of the National Health Interview Survey. J Clin Oncol. 2002;20:4581–90.
21. Punekar RS, Short PF, Moran JR. Use of psychotropic medications by US cancer survivors. Psychooncology. 2011; 10:1002/pon.2039.
22. Zuvekas SH. Prescription drugs and the changing patterns of treatment for mental disorders, 1996–2001. Health Aff (Millwood). 2005;24:195–205.
23. Erikson C, Schulman S, Kosty M, et al. Oncology workforce: results of the ASCO 2007 Program Directors Survey. J Oncol Pract. 2009;5:62–5.
24. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28.
25. Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117:2791–800.
26. Helf M, Mahon SM, Eden KD, et al. Screening for skin cancer. Am J Pub Health. 2001;20(Supp1):47–58.
27. Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.
28. Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11:188–98.
29. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.
30. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 Suppl):IV-104–17.
31. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25:47–54.
32. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284–92.
33. Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–76.
34. Manning, WG., Morris, CN, Newhouse, JP. A two-part model of the demand for medical care: preliminary results from the Health Insurance Study. In: van der Gaag, J., Perlman, M. (Eds.), Health, Economics, and Health Economics. North Holland, Amsterdam; 1981. p. 103–123.
35. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005;24:465–88.
36. Graubard BI, Korn EL. Predective margins with survey data. Biometrics. 1999;55:652–9.
37. Hoffman KE, McCarthy EP, Recklitis CJ, et al. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009;169:1274–81.
38. National Comprehensive Cancer Network. NCCN practice guidelines in oncology: Distress management. v.1.2010. http://www.oralcancerfoundation.org/treatment/pdf/distress-2008.pdf. Accessed 04/28/14